Cargando…
Applicability of a new specialty pharmacy-reported measure describing completion of therapy for hepatitis C
BACKGROUND: In 2019, the Utilization Review Accreditation Commission (URAC) required a new reporting measure for specialty pharmacies related to completion of therapy for hepatitis C virus (HCV). OBJECTIVE: To calculate HCV completion of therapy according to URAC criteria and compare it with a calcu...
Autores principales: | Bolduc, Clay, McCall, Kenneth, Stickney, Kirsten, Gelinas, Alycia, Levesque, Eileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391126/ https://www.ncbi.nlm.nih.gov/pubmed/33506724 http://dx.doi.org/10.18553/jmcp.2021.27.2.263 |
Ejemplares similares
-
Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy
por: Cooper, Megan Pendley, et al.
Publicado: (2022) -
Development and Implementation of Clinical Outcome Measures for Automated Collection Within Specialty Pharmacy Practice
por: Patel, Katherine, et al.
Publicado: (2020) -
Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy
por: Lankford, Cory, et al.
Publicado: (2021) -
The Emergence of Specialty Pharmacy
por: Vanscoy, Gordon J.
Publicado: (2020) -
The Reemergence of Specialty Pharmacy
por: Vanscoy, Gannon, et al.
Publicado: (2020)